Safety and immunogenicity of mRNA COVID-19 vaccine in inpatients with muscular dystrophy.

Tomoko SaitoToshio SaitoMasahide OkiKatsuhisa OgataMichio KobayashiHiroto TakadaSatoshi KuruTakashi KimuraAkinori NakamuraTsuyoshi Matsumura

Published in: Muscle & nerve (2022)

COVID-19 vaccination is safe and immunogenic in inpatients with MD. Patients with DM1 appear to have a poorer COVID-19 antibody response than those with other MDs. This article is protected by copyright. All rights reserved.

Keyphrases

coronavirus disease
sars cov
muscular dystrophy
molecular dynamics
duchenne muscular dystrophy
type diabetes
metabolic syndrome